ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.072,94
-0,01%
Brent Oil
83,76
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSXV
  6. Sirona Biochem Corp (SBM)

  7. Sirona Biochem Corp (SBM) Notícias

SBM

Sirona Biochem (SBM)

Sirona Biochem Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSXV:SBM
DataHoraFonteTítuloCódigoCompanhia
24/10/202323:58PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:SBMSirona Biochem Corp
20/12/202105:00PR Newswire (Canada)Sirona Biochem Antiviral Compounds to be Tested Against SARS-CoV-2 by Top US Testing FacilityTSXV:SBMSirona Biochem Corp
16/12/202105:00PR Newswire (Canada)Sirona Biochem Announces Engagement of Pullan Consulting to Close Optimal Deal for TFC-1067TSXV:SBMSirona Biochem Corp
13/12/202111:00PR Newswire (Canada)Sirona Biochem Provides Update on SGLT2 Inhibitor for Type 2 Diabetes in ChinaTSXV:SBMSirona Biochem Corp
10/11/202116:48PR Newswire (Canada)Sirona Biochem Announces 2021 Annual Meeting Results: Shareholders Approve All Resolutions With Majority VoteTSXV:SBMSirona Biochem Corp
12/10/202110:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem: Investing News Network Interview with CEO, Dr. Howard Verrico/TSXV:SBMSirona Biochem Corp
12/10/202104:00PR Newswire (Canada)Sirona Biochem: Investing News Network Interview with CEO, Dr. Howard VerricoTSXV:SBMSirona Biochem Corp
06/10/202110:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Announces Advancement of TFC-1067/TSXV:SBMSirona Biochem Corp
06/10/202104:00PR Newswire (Canada)Sirona Biochem Announces Advancement of TFC-1067TSXV:SBMSirona Biochem Corp
22/09/202110:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Announces Discovery of Anti-Cellulite Activity in Compounds/TSXV:SBMSirona Biochem Corp
22/09/202104:00PR Newswire (Canada)Sirona Biochem Announces Discovery of Anti-Cellulite Activity in CompoundsTSXV:SBMSirona Biochem Corp
30/06/202110:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem CEO Quarterly Update Q2 2021/TSXV:SBMSirona Biochem Corp
30/06/202104:00PR Newswire (Canada)Sirona Biochem CEO Quarterly Update Q2 2021TSXV:SBMSirona Biochem Corp
31/03/202110:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Reports Excellent Results in New Clinical Study on TFC-1067/TSXV:SBMSirona Biochem Corp
31/03/202104:00PR Newswire (Canada)Sirona Biochem Reports Excellent Results in New Clinical Study on TFC-1067TSXV:SBMSirona Biochem Corp
10/03/202111:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067/TSXV:SBMSirona Biochem Corp
10/03/202105:00PR Newswire (Canada)Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067TSXV:SBMSirona Biochem Corp
24/02/202111:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem CEO Quarterly Update Q1 2021/TSXV:SBMSirona Biochem Corp
24/02/202105:00PR Newswire (Canada)Sirona Biochem CEO Quarterly Update Q1 2021TSXV:SBMSirona Biochem Corp
03/02/202120:00PR Newswire (Canada)Sirona Biochem Announces Grant of Stock OptionsTSXV:SBMSirona Biochem Corp
15/12/202008:05PR Newswire (Canada)Sirona Biochem Signs Agreement with Luxembourg-based CURE Intelligence for Social Media and Communications SupportTSXV:SBMSirona Biochem Corp
30/11/202011:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Releases CEO Letter to Shareholders/TSXV:SBMSirona Biochem Corp
30/11/202005:00PR Newswire (Canada)Sirona Biochem Releases CEO Letter to ShareholdersTSXV:SBMSirona Biochem Corp
26/10/202010:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic Dermatology/TSXV:SBMSirona Biochem Corp
26/10/202004:00PR Newswire (Canada)Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic DermatologyTSXV:SBMSirona Biochem Corp
13/10/202010:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of its Novel Skincare Co...TSXV:SBMSirona Biochem Corp
13/10/202004:00PR Newswire (Canada)Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of its Novel Skincare Compound TFC-1067TSXV:SBMSirona Biochem Corp
09/09/202010:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067/TSXV:SBMSirona Biochem Corp
09/09/202004:00PR Newswire (Canada)Sirona Biochem Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067TSXV:SBMSirona Biochem Corp
16/06/202010:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Ships First Batch of TFC-1067 to Rodan + Fields/TSXV:SBMSirona Biochem Corp
 Apresentando as notícias mais relevantes sobre:TSXV:SBM

Seu Histórico Recente

BIT
S24923
SG ISSUER
COIN
ADCUSD
BIT
UC4AYG
Unicredit Bank
NASDAQ
SPKAR
SPK Acquisition
COIN
POLYXUSD
Polymesh
BOV
ITUBT354
ITUBT354 Ex:34,16
AMEX
EFSH.WS
1847
BOV
VALEL680
VALEL680 Ex:65,33
LSE
AG14
Citi Fun 24
BIT
F19192
Vontobel Financial Produ...
COIN
AC3USD
TG
BHI
Black Hills
USOTC
LBLCF
Loblaw Companies (PK)
COIN
APCBTC
NASDAQ
AGFY
Agrify
LSE
NRGT
Wt Energytmetal
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados